We are Sorry, This Page doesn't Exist
ContraFect Reports First Quarter 2021 Financial Results and Provides Business Update
Interim futility analysis from the Phase 3 DISRUPT study of exebacase evaluating treatment superiority is anticipated in H2 2021 BARDA contract award provides up to $86.8 million for exebacase development Strong fi.....»»
Diffusion Pharmaceuticals reports results from Phase 1b study of TSC
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mirum Pharmaceuticals reports Q1 EPS ($1.68), consensus (69c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ocugen partner Bharat Biotech reports analysis of Phase 3 study of COVAXIN
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Corbus Pharmaceuticals reports last subject visit in Determine phase 3 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mirum Pharmaceuticals announces FDA acceptance of maralixibat NDA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mirum Pharmaceuticals reports Q4 EPS ($1.43), consensus (72c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aslan Pharmaceuticals reports "positive" results from study of ASLAN004
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Benitec Biopharma reports results from interim analysis of BB-301 dosing study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mirum Pharmaceuticals reports Q1 EPS (86c), consensus (82c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Apellis reports analysis from Phase 1b geographic atrophy study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Celsion reports sufficient events reached in analysis of Phase III OPTIMA study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eton Pharmaceuticals reports bioequivalence study results for ET-101
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
Completed enrollment for the pivotal REST-ON Phase 3 study in Q4 2019; data readout expected in Q2 2020 Raised $65 million in gross proceeds from privat.....»»
Citius Pharmaceuticals reports positive Phase 3 Mino-Lok futility analysis
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mirum Pharmaceuticals completes pre-NDA meeting with FDA for maralixibat
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Xeris Pharmaceuticals reports "positive" phase 2 data in glucagon study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Agios Pharmaceuticals reports new data from DRIVE PK Phase 2 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aslan Pharmaceuticals reports preliminary data from ASLAN004 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mirum Pharmaceuticals And Maralixibat In Alagille Syndrome
Mirum Pharmaceuticals And Maralixibat In Alagille Syndrome.....»»